Pretreatment of Mesenchymal Stem Cells Manipulates Their Vasculoprotective Potential While Not Altering Their Homing Within the Injured Gut

Mesenchymal stem cells (MSCs) have shown therapeutic promise in many experimental and clinical models of inflammation. However, a commonly reported feature of MSC transplantation is poor homing to injured tissues. Previously, we have shown that pretreatment with cytokines/chemical factors enhances h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanagh, Dean P.J., Suresh, Shankar, Newsome, Philip N., Frampton, Jon, Kalia, Neena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Tissue‐Specific Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737111/
https://www.ncbi.nlm.nih.gov/pubmed/26124062
http://dx.doi.org/10.1002/stem.2061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737111/
https://www.ncbi.nlm.nih.gov/pubmed/26124062
http://dx.doi.org/10.1002/stem.2061

Ejemplares similares